CHU de Dijon-Hopital d'Enfants-Service d'hematologie Clinique

Dijon 21000

0 studies enrolling now · 1 studies all time

What they study most

Acute Lymphoblastic Leukemia

Studies at this site

• A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed